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Little more thon a year ago, a mummified child from the Saint Louis Science Center was brought to Washington
University Medical Center as part of a research study that included computed tomography scanning, DNA testing,
and radiocarbon dating. When study results were announced at the March 1 Sth Science Center news conference,
media around the world—including ABC's Good Morning America, the Washington Post, and China's Xinhua News
Agency—were fascinated with the story of this unknown child. Scientific findings showed that the mummy was a
male infant (age: six to eight months) and lived approximately 2,000 years ago.
For more information about the child mummy exhibit at the Science Center, visit www.slsc.org. For more information about the Institute's involvement in this research, visit the Electronic Radiology Lob at http://erl.wustl.edu/.
Photograph by Kimberly Kania, MIR Photography lab.
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4 king Tumors, Saving Lives
SPOT NEWS

Interventional radiologists and
urologic surgeons use cryoablation—
a less-invasive, computed tomography-guided technique—to treat
kidney tumors.

1 OThe Skinny on Fat

A collaborative study led by radiologists and internists shows that
magnetic resonance imaging can
effectively screen abdominal
fat in obese adolescents.

Washington
iiversityinStLouis

HOOL OF MEDICINE
J Mallinckrodt Institute
I of Radiology

12 A Window into the Heart

Armed with the latest CT and MRI
technology, a team of radiologists
and cardiologists provide better
care for patients with coronary
artery disease.

8 Predicting Cervical Cancer
Treatment Outcomes

Several studies involving positron
emission tomography, a valuable
tool in cancer diagnosis, may
change treatment modalities for
patients with cervical cancer.

2 1 Keeping Tabs on Multiple Sclerosis

Three investigators discuss a magnetic resonance technique, called
diffusion tensor imaging, used to
track tissue damage in patients
with multiple sclerosis.

ON THE COVER Radiologist Pamela Woodard and
cardiologist Benico Barzilai will head one of Missouri's

Visit the MIR web site at
www.mir.wustl.edu

first interdisciplinary cardiac imaging groups.
Photograph by Tim Parker.
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Matching
Program
results are in

39th Wilson
Award
presented

The 2007-2008 resident
training programs begin on
July 1. This year, the Institute
welcomes 18 trainees who
come from these excellent
schools:
• David Geffen School of
Medicine at the University
of California, Los Angeles
• University of Alabama
School of Medicine
• Vanderbilt University
School of Medicine
• University of Wisconsin
School of Medicine and
Public Health
• University of Iowa Roy J.
and Lucille A Carver College
of Medicine
• Emory University School
of Medicine
• Georgetown University
School of Medicine
• University of Louisville
School of Medicine
• University of Washington
School of Medicine
• Indiana University School
of Medicine
• Southern Illinois University
School of Medicine
• Saint Louis University
School of Medicine
• University of Utah School
of Medicine x
• The Chicago Medical
School at Rosalind
Franklin University of
Medicine and Science
• Washington University in
St. Louis School of Medicine.

Jennifer (Jeni) Sprague,
a student in the Medical
Scientist Training Program,
received the 2006-2007 Hugh
M. Wilson Award for Meritorious Work in Radiology. The
award honors Mallinckrodt
Institute's second director
and is presented as part of
Washington University in
St. Louis School of Medicine's
(WUSM's) commencement
program.
Sprague earned an
undergraduate degree in
biochemistry (with highest
honors) at Indiana University and received a combined
medical/doctoral degree at
WUSM. She completed her
doctoral research in Mallinckrodt Institute's Radiological
Chemistry Laboratory.
Under the mentorship of
Carolyn Anderson, PhD,
professor of radiology and
associate professor of
molecular biology and
pharmacology, Sprague's
research combined basic
science and translational
research in the evaluation of
radiopharmaceuticals for

Researcher Carolyn Anderson (left) in the lab with Jennifer Sprague

early diagnosis and monitoring of cancer metastasis
using positron emission
tomography (PET).
As a result of Sprague's
work involving the radiochemistry, characterization,
and biological evaluation of
copper-64, a tracer used
with PET for cancer imaging,
her research was published
in four scientific journals:
Clinical Cancer Research,
Nuclear Medicine and
Biology, Journal of Nuclear
Medicine, and the Journal of
Medicinal Chemistry.
"While performing her
dissertation research in my
lab, Jeni had outstanding

ideas toward the progress
and direction of her project
and demonstrated scientific
maturity well beyond her age
and experience," says Anderson. "Jeni's insight and
curiosity have led to some
very exciting discoveries
regarding the development
of novel imaging agents and
imaging strategies. What
makes her truly exceptional,
however, is the combination
of her scientific and personal
maturity, profound curiosity,
and unbelievable organizational and time-managemeni
skills. I have been extremely
fortunate to have a student
of such caliber working in
my group"

Welch speaks at Nobel
Conference

(

1

Michael Welch, PhD, professor of radiology, of chemistr;
and of molecular biology and pharmacology, presented an
overview of "PET imaging using nonstandard radionuclides"
at the Nobel Conference, Watching Life through Molecular
Imaging. The conference was held in the Nobel Forum—whe
the Nobel Prize in Physiology or Medicine is selected—at the
Karolinska Institute in Stockholm, Sweden. Prior to the Nobt
Forum, Welch, cochief of Mallinckrodt Institute's Division
of Radiological Sciences, was keynote speaker at the 1701
International Symposium on Radiopharmaceutical Sciences
in Aachen, Germany.

MALLINCKRODT INSTITUTE OF RADIOLOGY

MIR team excels in imaging
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The Institute's diagnostic
radiology resident/faculty
team was the big winner—
for the third time— in the
Philips Vydareny Imaging
Interpretation Competition
at the 55'" Annual Meeting
f of the Association of Univer: sity Radiologists (AUR).
Team members: doctors
Kristopher Cummings,
Joseph Erinjeri, and Jack
Jennings-2006-2007 diagnostic
radiology chief residents;
^onstantine Raptis-secondyear resident; Jennifer
)emertzis, Meghan Lubner,
nd Sara Rohr-third-year
residents and the 2007-2008
liagnostic radiology chief
residents; Jeffrey Carenza
fourth-year resident; Daniel
I'essell, musculoskeletal
adiology clinical fellow and

2005-2006 diagnostic radiology
chief resident; Jennifer
Gould, assistant professor of
radiology and director of the
Diagnostic Radiology Residency Training Program at
Mallinckrodt Institute;
Christine Menias, assistant
professor of radiology and
residency program assistant
director; and Sanjeev Bhalla,
assistant professor of radiology and residency program
assistant director.

Jennifer Gould, MD, accepts the award from Reed Dunnick, MD, AUR president.
In the huddle: (seated, left to right)
Daniel Wessell, MD, PhD; Christine
Menias, MD; Sanjeev Bhalla, MD; and

fl£ .,J*

Jennifer Gould, MD. (Standing, left to
right) Jennifer Demertzis, MD;
Constantine Raptis, MD; Kristopher
Cummings, MD; Joseph Erinjeri, MD,
PhD; and Sara Rohr, MD.

Research
fellowship is
available
Bayer HealthCare has
funded a fellowship for
I research involving contrast| enhanced magnetic resonance imaging (MRI). Jeffrey
Brown, MD, professor of
radiology, director of clinical
research, and cochief of
body MRI, will administer
the one-year fellowship that
will begin in November 2007.
For more information about
' the fellowship and the application process, go to the
"tfallinckrodt Institute of
adiology Web site at
v.mir.wustl.edu.
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WUSM among nation's top schools
In the 2007 U.S. News & World Report rankings, Washington University in St. Louis
School of Medicine (WUSM) retained its fourth overall ranking among research-oriented
medical schools and continues to hold first place in student selectivity (based on college
grade-point averages and MCAT scores). Among the top schools are Harvard University
(ranked first); Johns Hopkins University (second); University of Pennsylvania (third);
University of California, San Francisco (fifth); University of Washington (sixth); Stanford
University (seventh), Duke University and Yale University (tied for eighth place).
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Using cryoablation to destroy kidney-tumors
side the procedure room, the patient's computed tomography (CT)
scan shows a tiny tumor sitting squarely in the middle of his left
kidney—a challenging spot for resection. Further complicating
"case is the patient's medical history. Years before, he had
his right kidney to another tumor, and removing too much
lis remaining kidney will compromise its function, sentencing him to a lifetime of dialysis treatment.
For most patients with early-stage kidney
tumors, surgery is still the standard of care. But this
man, like a growing number of others for whom
surgery is not an option, will undergo a newer,
less-invasive radiological procedure: cryoablation.
On the CT image, the two percutaneously
(through the skin) placed needles appear,
releasing a liquefied, inert gas (argon) into the
tumor area. Suddenly, an ice ball forms, enveloping
the tumor. After 10 minutes of freezing, five
minutes of thawing with helium gas, and 10
more minutes of freezing, the procedure
is complete.

■Mi

T" M T'eeks later,
I /■ / during the
1/ 1/ patient's
■ * follow-up
examination, the
tumor appeared to
be totally destroyed,
says Daniel Brown,
MD, an interventional radiologist at
Mallinckrodt Institute who performed
the cryoablation in CASE 1: Computed tomography (CT) images of a 75-year-old female with a 4 cm tumor in the upper pole of her kidney. Patient is not a good
candidate for surgery.
collaboration with
urologic surgeon
Sam Bhayani, MD.
is still considered investigational
is seen in the Interventional Oncology
The two physicians have collabobut has so far had very promising
and Urology Clinic at the Washington
rated on the 25 cryoablations that
results. Papers published recently
University Medical Center so
have taken place at Barnes-Jewish
by
three other medical centers—
Brown and Bhayani can decide
Hospital over the past two years.
Johns Hopkins, the Mayo Clinic,
together whether to recommend
Before each procedure, the patient
and Wayne State University
surgery or cryoablation. After the
—showed only a handful of recurprocedure, the patient
rences among patients treated by
is seen in the clinic,
cryoablation during the first year
and images are reviewed
of follow-up care.
to determine whether
"We need to eliminate those
the tumor has been
recurrences before we can consider
adequately treated.
this as a replacement therapy for
"We have a wellsurgery, and we're still a long way
formed cooperative
from that. We also need to track its
relationship that has let
long-term outcome," says Brown.
us deliver the best care
"But in the meantime, for patients
to the patients," says
who are not surgery candidates,
Brown, associate prothis is a wonderful option."
fessor of radiology and
of surgery. "This is an
Background of the Cancer
interdisciplinary effort,"
Renal cell carcinoma is a fairly
adds Bhayani, assistant
rare tumor: seventh or eighth most
professor of urology
common among men and twelfth
and of surgery. "The
most common among women.
patients benefit because
In the United States, some 35,000
they get an opinion
new cases are diagnosed each year,
from an expert in kidney
most of them among people in their
surgery and from an
50s. While there is a weak link
expert in interventional
between smoking and the developoncology."
ment of this cancer, the cause is
The procedure
largely unknown. The number of
Brown and Bhayani have
patients with kidney cancer overall
pioneered at Washingalso is growing, for reasons that
ton University Medical
are likewise unclear.
Center, a national
leader in ablation,
Above: Doctors Sam Bhayani (left) and Daniel Brown
Left: Renal cell cancer
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Icing Tumors,
Saving Lives
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CASE 1: Images taken during the procedure show an ice ball surrounding the tumor.

"We have identified some of
the genetics behind renal cell
carcinoma," says Bhayani, "but we
don't know yet why certain genes
mutate, causing these cancers to
form. So although we've made
great strides, we don't have the
full information as yet."
Some 30 years ago, before the
advent of CT scans and magnetic
resonance imaging, these tumors
were nearly always discovered
when patients found blood in
their urine or felt a pain in their
side. By then, the masses were
large, up to eight or nine centimeters
in size, and surgical
removal was the
only option.
Bhayani's study,
published in the
Journal of Urology in
2006, shows that this
picture has changed
dramatically. With
new imaging technologies, some 80 percent
of patients who were
recently diagnosed
^
^
with kidney cancer at
Barnes-Jewish Hospital
had no symptoms,

and their renal tumors were picked
up incidentally on CT scans that
were taken for other reasons.
These masses may be tiny (1 to 4
centimeters in size), which makes
them good candidates for ablation.

The Cryoablation Procedure
For years, radiofrequency (RF)
ablation—the heat-based cousin
of cryoablation—has been used
effectively to fight liver, lung, and
bone tumors. As in cryoablation,
radiologists insert needles into the
tumor, but these needles carry a
current that heats up the tissue and
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kills the cells. The problem is that
RF ablation is painful and requires
significant sedation or general
anesthesia. Cryoablation, which is
much less painful, works better
on kidney cancers and also on
patients for whom anesthesia is
risky, including those with poor
heart function or damaged lungs
because of smoking.
Age also is a factor. For older
patients, cryoablation may work
well, even if its long-term results
should prove to be slightly less
effective than surgery. "If the
cancer comes back in twenty
years and the patient is seventyfive or eighty, then the recurrence
may not be as emotionally difficult
for the patient," says Bhayani.
Cryoablation—also used by
urologists in laparoscopic procedures
—involves CT guidance, slender
needles, and gases. Once the
needles are inserted through the
skin and into the kidney, they
deliver argon gas into the tumor.
The temperature at the needle tip
reaches minus 140 degrees, and ice
begins forming instantly. Away
from the needle tip, the temperature
rises somewhat, but a range of minus
20 to minus 40 degrees is still lethal
to tumors.
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I: These images taken after cryoablation show an absence of contrast enhancement of the tumor—a finding compatible with
a successful procedure.

MALLINCKRODT INSTITUTE OF RADIOLOGY

With cryoablation, radiologists
cannot rely on sending a specimen
to pathology. Still, the results to
date indicate that the procedure is
remarkably effective. Preliminary
national data shows an effectiveness rate of 93 percent or 94
percent. Of the 25 patients treated
at Barnes-Jewish Hospital, only
two have had any residual tumor.
Both patients were successfully
treated at a second visit.
Once kidney cancer has
metastasized, it is uniformly fatal,
so physicians want to catch any
recurrence early on. Radiological

• Kidney Cancer Association:
www.kidneycancer.org
• National Cancer Institute:
http://cis.nci.nih.gov/

• American Cancer Society:
www.cancer.org

complications. With a highly
vascular organ like the kidney, there
is always the chance of a small vein
oozing blood, which could potentially require a blood transfusion.

Pros and Cons of
Treatment Options
• Is the ice ball surrounding the
tumor? Up to eight needles can be
used for a larger area of "cell kill."
"As you put more needles in, it
actually becomes a multiplying
rather than an additive effect," says
Brown. "The needles synergize,
and the ice ball gets bigger."
The patient stays in the hospital
overnight in case of any bleeding
FOCAL SPOT, SPRING 2007

Surgical excision has a key
advantage over cryoablation for small
kidney tumors: Surgeons can cut
out the mass and send the marginal
cells to pathology for analysis, to
see whether all the cancer was
removed. Since kidney cancer is
categorized into five subtypes, each
with its own characteristics, cellular
analysis also can tell doctors how
aggressive the tumor was, which
will give them prognostic data.

follow-up is crucial. After undergoing cryoablation, patients return to
Mallinckrodt Institute for CT scans,
taken at one month, then three to six
months, and thereafter at regular
intervals indefinitely. Surgical
patients also require follow-up care,
though less frequently.
Overall, cryoablation as a treatment for kidney tumors means one
more option for patients, say both
physicians. "If you are going to offer
the full range of treatments for
patients with renal cell carcinoma,
cryoablation is an important part of
their decision making," says Brown.
"Ultimately, patients benefit because
they can choose among various
options—and all the options are
effective," says Bhayani. EH

Positron emission
tomography (PET),
an imaging method
developed at Mallinckrodt
Institute of Radiology (MIR) in
the early 1970s, has become a
valuable tool in cancer imaging.
Malignant tumors tend to devour
more sugar (glucose) than do benign
tumors. PET imaging of cancer typically involves the use of a radioactive
glucose-based analog, or compound,
called fluorodeoxyglucose (FDG).
Ultimately, abnormal FDG uptake
appears as "hot spots" (brighter
areas) on PET images. In some
types of cancers, it has been shown
that if a PET scan is done prior to
chemotherapy and again midway
through treatment, changes in
glucose uptake can be tracked to
determine if the tumor is responding
to therapy or if the treatment plan
should be changed. The patient can
then be spared the adverse effects
H

of a therapy that is not affecting the
cancer. Now studies have shown
that PET is useful in predicting
relative survival rates for patients

i

with cervical cancer.

Perry Grigsby, MD, a radiation
oncologist and director of the
Brachytherapy and microRT
treatment centers at the Siteman
Cancer Center, says glucose uptake
may vary more in cervical cancers
than in other types of cancers.

Radiation oncologist Perry Grigsby

Glucose uptake appears to be
greater in cervical tumors that are
not responding to treatment, independent of the size of the tumor.
In Grigsby's research, each cervical
tumor was assigned a maximal
standardized uptake value (SUVmax,
and referred to in this article as
SUV) based on how much glucose
was used: the higher the SUV, the
higher the risk of lymph node
metastases, and the lower the
patient's survival rate.

STUDY FINDINGS
The mean SUV was 10.2 in
the first study group of 96 patients.
Patients whose tumors had an
SUV below the mean had a five-year
survival rate of 71 percent; those
above, a 52 percent chance of
surviving five years without
a recurrence.
"By the time an article was
published in the April 2006 issue
of Gynecological Oncology, we had
doubled the number of patients
in the study, and it was clear that
Left: PET/CT image shows the cervical cancer (solid
white area) and radiation doses (brightly colored areas).
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there were really three demarcations in the data," says Grigsby, a
professor of radiation oncology,
of radiology, and of obstetrics and
gynecology. "Based on a statistical
model, we assigned two hundred
and eighty-seven patients into three
separate survival-rate groups."
According to Grigsby, at the
patients' five-year follow-up examinations, the results were remarkable:
• 95 percent of patients with an
SUV below 5.2 were disease-free.
• Survival rate for patients with an
SUV between 5.2 and 13.3 was 70
percent.
• 44 percent of patients with an
SUV over 13.3 were disease-free
at five years.
Follow-up examinations at
seven to eight years showed more
marked differences in the patients
who were disease-free:
• 90 percent of patients with an
SUV below 5.2,
• 75 percent with an SUV between
5.2 and 13.3,
• 10 percent with an SUV over 13.3.
Grigsby's research also showed
there was a great deal of heterogeneity within the cervical tumors.
A tumor's high SUV score did not
apply to the whole tumor, only a
part of it. Grigsby and fellow
researchers are attempting to identify
which areas of the cervical tumor
are high in glucose uptake and
whether the SUV makes a difference
in prognosis.

ADDITIONAL
RESEARCH
Another project in the works
is examining the genes responsible
for high glucose uptake. The research
team identified some genetic changes
in tumor biopsies; they want to see
if those results are consistent across
a larger group.

STATISTICS
CERVICAL CANCER STATISTICS
"■ This year in the United States,
approximately 11,150 cases of
invasive cervical cancer will
be diagnosed.
In 2007, some 3,600 women in
the United States will die from
cervical cancer.
The death rate from cervical
cancer continues to decline by
nearly four percent each year.
Half of the women diagnosed
with cervical cancer are between
the ages of 35 and 55.
Around 20 percent of women
with cervical cancer were
diagnosed at age 65 or older.
The overall (all stages combined)
five-year survival rate for women
diagnosed with cervical cancer
is about 72 percent.
Before Pap smears (also called
Pap test, Papanicolaou smear, or
cervical smear) were in general
use, cervical cancer was the
second leading cause of cancerrelated deaths in the world.
In developing countries, cervical
cancer still has a 50 percent
mortality rate.
For more information,
go to the American Cancer Society
Web site: www.cancer.org.

PRFDTrTTNC
Cervical Cancer Treatment Outcomes

HETEROGENEITY OF FDG UPTAKE IN PRIMARY CERVICAL CANCERS
Co-occurrence matrix (or 40% SUV

Co-occurrence malrix for 40% SUV
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They also are looking at the
role of human papilloma virus (HPV)
in those tumors. "We know that
ninety-nine percent of cervical
cancers are caused by HPV," says
Grigsby. "Once the patient is diagnosed with cancer, physicians typically
concentrate on curing the cancer,
not the HPV. There's no consensus
as to whether that's the right decision.
When the cancer starts to grow, no
one has asked what the current
role of HPV is in this disease."
Grigsby is particularly interested
in the virus because of the other

HPV-related malignancy—anal cancer. "Both cervical and anal cancers are of the squamous-cell types
and are caused by HPV," he says.
"We've been using PET to study
cervical cancer for nine years, and
studies of anal cancer in tandem
with cervical cancer have been
active for the last two years. The
findings are strikingly similar.
There's a good chance that any
changes in treatment modalities
that come out of this study will
apply to both types of cancer."

"The SEER report card [Surveillance Epidemiology and End
Results, a source of information on cancer incidence and
survival in the United States] published by the National
Cancer Institute still ranks cervical cancer as third in the
average years of life lost from cancer deaths, ranking behind
childhood cancers and testicular cancer, which tends to affect

0

PET POTENTIAL
Farrokh Dehdashti, MD, a
nuclear medicine physician at MIR,
expands on clinical PET studies:
"As yet, there are no standards in
place for changing a course of
treatment based on a tumor's high
FDG uptake, as measured by SUV;
thus, we watch these patients
closely and use PET following
completion of therapy to assess
response to therapy and to detect
early recurrence."
Dehdashti, a professor of
radiology, is especially encouraged
by her research involving the
measurement of tumor oxygenation
in patients with cervical cancer.
"A special hypoxic marker measures
the oxygenation of the tumor,"
she says. "We know that well
oxygenated tumors respond better
to radiation as compared to low
oxygenated [hypoxic] tumors.
Our initial study involved fourteen
patients with cervical cancer.
Now, we have completed the study
of thirty-eight patients and found
similar results."

younger, rather than older, men." —PERRY GRIGSBY, MD

10
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The PET hypoxic tracer first
used by Dehdashti was Copper60-ATSM (Cu-60-ATSM), which,
because it has a 24.5 minute
half life, must be produced on a
nearby cyclotron. This study was
performed with institutional
approval and was done at Washington University School of Medicine
with the availability of the three
cyclotrons housed at Mallinckrodt
Institute. In order to make this
radiopharmaceutical more widely
available, the radiochemistry team
wanted to produce Cu-64-ATSM.
Since Cu-64 has a 12.7 hour half
life, it can be transported to medical

data for Cu-64-ATSM, which was
required for approval of the IND
by the FDA. Dehdashti and Barry
Siegel, MD, a professor of radiology
and chief of the Institute's Division
of Nuclear Medicine, have completed a study that compared PET
images using both tracers. If there
is no clear advantage for using
Cu-60, then the Cu-64 tracer can be
transported to other study centers,
which will greatly expand cervical
cancer research. ED

Radiochemist Jason Lewis

Administration (FDA)—which
was obtained with the help of the
Development of Clinical Imaging
Drugs and Enhancers (DCIDE) program at the National Cancer Institute.
Jason Lewis, PhD, an assistant
professor of radiology, obtained
the toxicology and pharmacology

Editor's note: Doctors
Dehdashti, Ghigsby, Lewis,
and Siegel recently were
invited to the National Cancer
Institute to discuss their role
in developing a multicenter
trial for Cu-64.

EVELOPMW
PET RADIONUCUDE DEVELOPMEPMENT AT MIR

Nuclear physician Farrokh Dehdashti

centers that are conducting
PET studies but do not have an
in-house cyclotron.
But first, the research team
had to determine if the quality of
PET images performed using
Cu-64-ATSM was comparable to
that of Cu-60-ATSM. In order to
study Cu-64-ATSM, it was necessary
to obtain an Investigational New
Drug (IND) approval from the
United States Food and Drug

FOCAL SPOT, SPRING 2007

The Cu-ATSM hypoxia selective radiopharmaceutical used in the
cervical cancer studies at Washington University School of Medicine
were developed in Mallinckrodt Institute's Radiological Chemistry
Laboratory as part of the Radionuclide Resource for Cancer Applications, a National Cancer Institute-sponsored program. The following
MIR scientists are involved in this program:
• Jason Lewis, PhD, an assistant professor of radiology and codirector
of the microPET imaging facility
• Michael Welch, PhD, a professor of radiology and of chemistry and
cochief of the Institute's Division of Radiological Sciences
• Thomas Voller, research laboratory supervisor.
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■NTURE FOR RADIOLOGY AND CARDIOLOGY
by Anne Kessen Lowell

I

1 promise quicker diagnosis of hidden health threats

in some patients. At Washington University in St. Louis, a
partnership that combines the top-level expertise of radiologists
and cardiologists with the cutting-edge technology of computed
tomography (CT) and magnetic resonance imaging (MRI)
will provide a greater understanding of coronary artery disease.

This joint venture will create
a new imaging group, an interdisciplinary team of radiologists and
cardiologists that will be part of
Mallinckrodt Institute of Radiology's
Cardiothoracic Imaging section.
The cardiac imaging staff will be
headed by Pamela Woodard, MD,
an associate professor at Mallinckrodt Institute, and Benico Barzilai,
MD, a professor in the Department
of Medicine's Division of Cardiovascular Disease. The partnership
is one of a handful of such interdisciplinary efforts in the country and
the only one in Missouri, according
to Woodard.
The cardiothoracic imaging
group will specialize in cardiac CT
angiography, using a CT scanner to
produce high-resolution, threedimensional images of coronary
arteries and cardiac anatomy and
using MRI to assess cardiac
morphology and function. "One
exciting aspect of this program is
the new CT technology that allows
us to acquire volumetric data
covering the heart at every phase
of the cardiac cycle, very rapidly,"
extols Woodard. "The technology
gives physicians a noninvasive tool
to view cardiac function."
The advent of the 64-slice CT
scanner in 2003 opened a wealth of
new applications in cardiac imaging
but also raised questions—some
would say controversy—about the
applicability and best use of the
new technology. Radiology centers
large and small have been snapping
up the $1.5 million machines in the
hope of attracting paying customers
who, although they have no symptoms, want to know more about
their own heart health. This joint
venture advocates a measured
approach and lets patient needs
dictate the role of technology.
Left: Three-dimensional, surface-rendered coronary
CT angiogram shows two saphenous bypass grafts
(white arrows). Red arrow points to a stenosis.
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The Radiology Group: (front row, left to right)
Doctors Fernando Gutierrez and Andrew Bierhals;
(second row, left to right) Doctors Pamela Woodard,
Cylen Javidan-Nejad, and Sanjeev Bhalla. Not shown:
Vamsidhar Narra.

The speed and resolution of
these newest CT scanners has
altered the diagnostic landscape.
The 64-slice CT scanner takes 64
images (in scanner nomenclature,
these are known as slices) in a
single revolution around the tube
in which the patient lays supine
for the exam. The duration that
patients must hold their breath
during the exam (known as the
"breath-hold") takes only a few
seconds. The resulting images are
richly detailed, showing the intricacies of the cardiovascular system,
including the exterior of coronary
arteries and vessels. In contrast,
invasive techniques can only reveal
what is going on in the interior of
the structures.
Cardiac CT angiography is
evolving into a powerful tool in the
battle against one of the deadliest
threats to heart health—coronary
artery disease. Sudden cardiac
deaths, primarily from heart attack
and stroke, number about one-half
million in the United States.

The Partnership
RADIOLOGY
Pamela Woodard, MD, associate professor
Sanjeev Bhalla, MD, assistant professor
Andrew Bierhals. MD, MPH, instructor
Fernando Gutierrez, MD, professor
Cylen Javidan-Nejad, MD, assistant professor
Vamsidhar Narra, MD, associate professor
CARDIOLOGY
Benico Barzilai, MD, professor
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The Cardiology Group: (left to right) Doctors Ibrahim
Saeed, Benico Barzilai, and Tillman Cyrus

o order a cardiac CT
■ cardiac MRI scan,
call CENTRAL

SCHEDULING

at (314) 362-71 11. For same
day add-ons or for a physician
consultation regarding an examination, page (314) 663-1010.
Scheduling of these examinations
must be done by a physician or
by the physician's office staff.

Most of the deaths, and many
more incapacitating heart attacks,
result from coronary artery disease. One reason heart attacks and
strokes are so feared among
healthy Americans is because they
frequently occur in people who
appear healthy and without warning or symptom. The death in 1982
of marathon-runner Jim Fixx drew
national attention to the lurking
nature of the disease. Fixx was
felled by a massive heart attack at
age 52; his autopsy revealed coronary occlusion in three arteries.
Although he had a family history of
heart disease, Fixx had no symptoms
and, in part due to his level of exercise, believed he was in excellent
health. Cardiac CT angiography
may lead to earlier diagnosis and
treatment of these silent threats to
heart health.

Coronary blockages are caused
by atherosclerosis, as fatty material
collects and thickens along the
interior walls of arteries. This hard
substance, called plaque, retards
blood flow through the artery and
also can break off in pieces, causing a heart attack or a stroke. And,
blood clots may attach onto plaque
material, further restricting blood
flow and also presenting the possibility of breaking off and causing a
stroke or a heart attack.
Some people experience chest
pain as a result of atherosclerosis;
tragically for many, there are no
symptoms before the disease
causes death. For those who do
have symptoms, the "gold standard" of screening techniques
remains cardiac catheterization.
In this procedure, the patient is
first injected with a contrast agent.
Then the cardiologist inserts a
guidewire, and over that a catheter,
into a major vein in the groin. As an
X ray views the heart, the physician
directs the catheter into the arteries
surrounding the heart, using it to
introduce additional contrast agent
to create more detailed X-ray images.
The advantage of the cardiac
catheterization is the ability to
combine diagnosis and treatment
in one procedure. If the degree of
blockage is severe, a different type
of catheter can be placed in the
vessel and the cardiologist can
insert a balloon that is used to
destroy the plaque and clots by
applying pressure into the balloon
and, thereby, against the walls of
the artery. Stents and other therapeutic devices can be inserted
through the catheter, if needed,
to give temporary or permanent
support to the artery walls.
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Radiologists and cardiologists
agree there is a place at the diagnostic table for cardiac CT angiography,
but they have yet to decide which
patients would most benefit. Because
30 to 40 percent of cardiac catheterizations do not show any blockage,
there is great interest in determining
a priori whether a particular patient
should have the less-invasive CT
procedure as an initial screening.
Barzilai acknowledges that
many unknowns must be addressed.
"On the one hand, there is the question of screening an asymptomatic
patient," he says. "If we find some
blockage, there may be some pressure to do something about it, even
if it is minor. On the other hand,
we aren't really sure what would
happen to that type of patient if
they were never evaluated."
For now, according to
Woodard, the test is an excellent
alternative for people with atypical
chest pain, inconclusive stress tests,
and chronic chest pain. Some
patients will indeed need to go
directly to cardiac catheterization.
Others may have noncoronary
cardiac disease that the CT option
will reveal in great detail, leading to
appropriate and targeted treatment.
"Cardiac CT angiography can
also help us determine the effect
of blockage on blood flow, and that
will help us choose the best treatment option," says Barzilai. "If
patients have a less-than-nfty percent
blockage, visible on CT, without
obstruction of blood flow, then we
can treat them with medicine."
Cardiac MRI also will play a role
in this joint venture. A cardiac-gated
version of MRI has been available
since the late 1980s; however, new
developments occur daily. Cardiac
MRI, long used for anatomic imaging, is now the reference standard
for ventricular function.

"Newer delayed contrast-enhanced techniques
can show the exact size
and location of myocardial
infarction unlike any
other test," says Woodard.
"The same technique can
be used for characterizing
cardiomyopathies not
caused by infarction and
may provide insight into
the etiology of a malfunctioning heart." Techniques
also are available to assess
the extent of valve disease
and to provide information
about whether a heart
valve should be replaced.
Both physicians are
certain of one thing: The
joint venture will lead to
better decision making and
optimal application of the
new technology. They are
proud of their role in promoting cooperation
between their disciplines.
"I hope we will set a benchmark for other institutions,"
says Woodard. "Patient
care is paramount, not
who owns the equipment."
Barzilai emphasizes
the benefits of the
approach in teaching
young physicians. "I'm
excited that I'll have
cardiology fellows sitting
next to radiology fellows,
treating the same patient.
The two disciplines bring
different thought processes
to the same table. I've
always believed it's easier
to collaborate with other
departments here at
Washington University than
at other places. I do it on a daily
basis. It is one of the strengths of
our institution." fSM

Top: This coronary CT ongiogram shows a stenosis
(arrow) in the distal right coronary artery (RCA).
Bottom: Delayed contrast-enhanced short axis
cardiac MR image demonstrates an inferoseptal
subendocardial infarction (arrow) of the
left ventricle.
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USING MRI TO FIGHT TEENAGE OBESITY
^^* I
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by Anne Kessen Lowell

esearchers at Mallinckrodt Institute are hunting for new
and effective ways to assess life-threatening risks to
adolescents from obesity, and they are forming partnerships with pediatric diabetic specialists and nutrition
experts to help these impressionable youngsters lead
healthier lives. One key to improving long-term health
of overweight teenagers is to understand the location
of fat within the abdomen. Magnetic resonance imaging
(MRI) turns out to be an excellent tool to map the composition of
abdominal fat—external (also called subcutaneous) and internal
(or visceral). Visceral fat poses greater danger to internal organs
and is associated with diabetes, heart disease, and nonalcoholic
fatty liver disease.

arilyn Siegel,
MD, professor of
radiology and of
pediatrics, is at
the forefront of
research using
imaging techniques
to understand
abdominal fat
distribution. In
the March 2007
issue of the journal Radiology,
Siegel described
her significant work using MRI
to assess the distribution of
fat in obese preadolescents
and adolescents.
MRI had been proven effective for measuring body fat in
adults, but only a few studies
had been done in children
(defined as ages six to 11 years)
and adolescents (ages 12 to 19
years). In terms of long-term
health and the likelihood of
developing serious disease, there
is bad fat and there is really
bad fat. External fat is easy to
see; we even give it names such
as "love handles" or "spare
tire." But internal fat, deep
inside the body and surrounding
abdominal organs, is much
harder to assess and much more
dangerous to an individual's
health. "Since so many serious
illnesses are correlated with intraabdominal fat, it is critical to find
an accurate way to measure it,"
says Siegel.
Although causality remains
a mystery, the measure of intraabdominal fat in teenagers is a
marker for a future beset by serious
complications. The obesity rate
among young people is skyrocketing,
and pinpointing the presence of
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As an Armed Forces Institute of Pathology Distinguished Scientist, Marilyn Siegel, MD, spent six months in Washington,
DC, studying the correlation between abnormal radiological images and their underlying pathological processes.

visceral fat may help to develop
effective prevention through diet
and exercise programs that literally
get beyond the surface.
"We set out to find a fast, reliable,
and safe technique to measure fat
in children. Different options had
been tried in the adult population
but not in a pediatric population.
We wanted to see if we could
improve accuracy and reduce
errors that tend to occur in nonradiological evaluations," says Siegel.

MEASURING BODY FAT
The current standard evaluation
to estimate total body fat is anthropometry, a physical examination
that measures circumference of the
waist and abdomen, height, and
body mass index (BMI). Anthropometry, when performed by
well-trained practitioners, may
yield an accurate measurement
of total fat. But the potential for
error is high if the practitioners
lack training.
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Another reliable method for
determining total body fat is dual
X-ray absorptiometry (DXA).
Although DXA is accurate for
estimating body fat, this technique
requires exposure to ionizing
radiation. In addition, both DXA
and anthropometry share a disadvantage: Neither test can give a
breakdown between subcutaneous
fat and the more harmful
intra-abdominal fat.
Siegel collaborated with
experts at Washington University
to measure total and intra-abdominal fat distribution in adolescents.
In this study, 30 adolescents had fat
tissue measurements taken by singlesection and whole abdominal,
multi-section MRI. The study's 20
boys and 10 girls were between the
ages of 10 and 18:
• Nine were overweight but did not
have diabetes.
• 10 had Type 2 diabetes and were
overweight.
• 11 were normal weight and did
not have diabetes.
The single-section and
multi-section MR measurements
were compared and tested for
correlations with anthropometric

Magnetic resonance (MR) image—involving True-FISP (Fast Imaging with Steady Precession, a technique using a fully
balanced gradient waveform)—of a 10 year-old, overweight girl: abdominal MR image (upper left), total abdomen
(upper right), and subcutaneous fat (lower left) and visceral fat (lower right) regions are segmented from the MR image.

and DXA measurements. The software that made the MR analysis of
fat distribution possible was developed in the Electronic Radiology
Laboratory at Mallinckrodt Institute.

S
CLINICAL
Marilyn Siegel, MD, professor of radiology and of pediatrics
Neil White, MD, CDE, professor of pediatrics

ANALYSIS
Kyongtae Bae, MD, PhD, associate professor of radiology
Charles Hildebolt, DDS, PhD, associate professor of radiology and
adjunct associate professor of anthropology

"The signal intensity of fat pixels
is higher than that of muscle and visceral organ pixels," explains Siegel.
"We can use MRI to separate and to
measure images of subcutaneous
and visceral fat and to calculate the
amount of each type as a percentage of total abdominal area."
The study produced encouraging results and suggests that MRI
can play a leading role in the fight
against childhood obesity. Fat
measurements using MRI—
both single-section and wholeabdominal, multi-section imaging—
strongly correlated with
anthropometric and DXA calculations. Even better, the singlesection examination, which takes
just a few seconds, proved to be as
accurate as the multi-section examination for characterizing body fat.

Cheng Hong, PhD, MD, research associate
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While all study volunteers had similar fat distribution patterns with a
predominance of fat in the tissues
of the abdominal wall, the total
amount of fat varied. Overall fat
volume was highest in the diabetic,
overweight adolescents.
"Now we have a safe, accurate,
and fast screening tool. Speed is an
important factor when working
with young patients," says Siegel.
"It's difficult to keep them immobile
for a lengthy examination."
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FORGING PARTNERSHIPS

Washington University's leadership in the study and treatment
of obesity-related illness is leading
to some exciting partnerships
between radiologists and internists.
Mallinckrodt Institute researchers
are contributing creative thinking
about the applicability of MRI and
ultrasound; University investigators
and clinicians bring knowledge and
sensitivity to patients (especially
younger ones) as well as the nuances
of treating a disease with a large
behavioral component.

In a separate study involving
adolescent obesity, Siegel is
collaborating with other Washington University researchers
to determine if ultrasound—an
inexpensive, readily available,
noninvasive technology—is a
viable tool for diagnosing nonalcoholic fatty liver disease
(NAFLD). Little is understood
about the cause of NAFLD, but
most specialists agree that it is
closely linked to increasing
rates of obesity.
"There is great concern
about the increasing prevalence
of NAFLD in children," says
Siegel. "NAFLD has been
reported to affect twenty-three
percent of overweight children.
Yet they may be completely
asymptomatic until the liver is
severely damaged."
Not all cases of NAFLD
result in symptoms or other
problems, and the course of the
disease is being investigated in
both adults and children. Until
now, the recommended test for
detecting NAFLD has been
proton magnetic resonance
spectroscopy, an expensive
technique requiring specialized
equipment and expertise.
Siegel reports that in her
study of 28 overweight adolescents, ultrasound was a reliable
tool for diagnosing moderate to
severe NAFLD. However, she
concludes that additional studies
to detect mild NAFLD are needed.
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Siegel and the research team
are passionate about making a
difference in young people's lives.
"If we successfully monitor the
progress and effectiveness of
different strategies, we can keep
children and teenagers from
becoming patients in the liver
transplant program and in the
cardiac catheterization and renal
dialysis labs. It's important to
help them make the connection
between being overweight and
developing a life-threatening
disease," observes Siegel.
"Their mantra has become,
'I'm too young for that; I won't get
sick.' But in St. Louis, in Missouri,
in the United States, young people
are becoming very ill as their
health falls prey to obesity," she
adds. "We need to help these kids,
and their parents, to recognize the
dangers and to help them take
action. The MRI procedures we
have developed are potentially
useful in many clinical and
research applications, including
planning patient management,
monitoring therapeutic interventions, and implementing multicenter
clinical trials." EH

OVERWEIGHT VS. OBESE
• Overweight children (defined as ages 6 to 11 years) and
adolescents (ages 12 to 19 years) are defined as being
at or above the 85th percentile of Body Mass Index
(BMI); obese children and adolescents, at or above the
95th percentile.
• Some researchers refer to the 95th percentile as overweight, while others refer to it as obese. The Centers
for Disease Control and Prevention (CDC), which provides national statistical data for the weight status of
American youth, avoids using the word "obesity" and
identifies every child and adolescent above the 85th
percentile as "overweight."
UNITED STATES STATISTICS
• The percentage of young people who are overweight
has more than tripled since 1980.
• Approximately 30.3 percent of children are overweight,
and 15.3 percent are obese. For adolescents, 30.4 percent are overweight and 15.5 percent are obese.
• Sixteen percent (nine million) of children and adolescents are overweight.
• Four in 10 Mexican-American and African-American
children and adolescents are overweight or are at risk
of being overweight.
• About sixty percent of obese children ages 5 to 10
years have at least one cardiovascular disease risk factor, including high cholesterol and triglycerides,
increased insulin levels, or high blood pressure. One
fourth of these children have two or more risk factors.
• Children and adolescents who are overweight by the
age of 8 years are 80 percent more likely to become
overweight or obese adults.
• Obesity is the second leading cause of all preventable
deaths in the United States.
Information available on these Web sites.
American Obesity Association:
www.obesity.org/subs/fastfacts/obesity_youth.shtml.
Shape of the Nation Report 2006:
www.aahperd.org/naspe/ShapeOfTheNation/PDF/
ShapeOfTheNation.pdf
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Multi
Researchers are using Vmagn etic resonance
imaging to study myeliri and nerve damage
*,py rs^pry Jo Blackwood, RN, MPH

Multiple sclerosis (MS) is a
devastating, and as yet, incurable
autokrfmune disease that affects
the central nervous system.
According io the National Multiple
Sclerosis Society {NMSS), anyone
can developMS; however, the
typical candidate is between the
ages of 20 and 50, a v&man (two
to three times more often than a
man), and of Northern European
descent. About 400,000 Americans
owledge having MS. Worldwide,
number may be 2.5 million.
The exact cause of MS is
loiQwn but, according to
researchers, symptoms of MS
probably are caused by damage to
the myelin sheath protecting nerves
and/or by damage to the nerves
themselves-. Tracking that damage
is becoming easier because of new
imaging tecrmjques that can help
to predict out^cfttie and prognosis,
as well as to differentiate between
MS and other 'clinical, less severe
look-alike^. *t

* |

The NMSS is currently funding
three studies at Mallinckrodt
Institute of Radiology that involve
diffusion tensor imaging (DTI),
a magnetic resonance imaging
(MRl) technique that enables the

Schwann
cell
Nucleus
STRUCTURE OF A TYPICAL NEURON

measurement of the restricted
diffusion of water in tissue. DTI's
principal application is in the
imaging of white matter where the
location, orientation, and direction of water molecule movement
can be measured.
Here, the lead investigators
discuss their important research.

-,,

Multiple
Sclerosis
Sheng-Kwei (Victor)
Song, PhD
Song, an associate professor
of radiology in the Biomedical Magnetic Resonance Laboratory, has
a three-year NMSS grant to study
the use of DTI in differentiating
between damage to myelin and
damage to the nerve fibers in
people with MS.

In Vivo DTI in Chronic EAE
Axial diffusivity

2.S

1.3

Clinical Score

Top and middle: a patient with optic neuritis, an early sign of MS.
Bottom: a model of experimental allergic encephalomyelitis (EAE)
mimics MS.

"Based on our work using
animal models of MS and other
white matter disease and injury,
we found that the movement of
water molecules in nerve fibers is
a potential marker for nerve injury,"
says Song. "Our research team was
able to conduct DTI studies on
nerve fibers from mouse models
of MS in vivo and confirm our findings through histological analyses."
"The current findings suggest
that this method is capable of
noninvasively reflecting damages
to nerve fibers and the protective
myelin sheath in the animal model,"
he adds. "We want to see if these
results with animal models can
translate to patients with optic
neuritis, an early sign of MS."

Song is working with groups
of patients with optic neuritis (an
early sign of MS that results in temporary or permanent vision loss) to
determine if DTI measurements are
predictive of good and bad recovery.
In the first study, the correlation of
DTI results indicating nerve injury
will be compared to visual function
in patients with chronic optic
neuritis. Since myelin
can regenerate and
nerves cannot, Song
is studying both
patient groups,
hoping to make a
correlation between
nerve damage, myelin
damage, or both.
The next study
will examine patients
at the onset of optic
neuritis, and then
again at three, six,
and 12 months
afterwards to track
changes and to
determine if poor
outcomes can be predicted. During
active optic neuritis, patients with
and without nerve or myelin damage will have similar symptoms;
DTI may give the treating physician
the currently unavailable information
on prognosis and treatment stratification. Song also is looking at spinal
cord damage in patients with MS.
"It was reported that ninety
percent of patients with MS have
spinal cord lesions over the duration of the disease," says Song. "In
a recent study of mouse models of
MS, our spinal cord DTI analysis
not only identified the diseased
animals from the control but also
correctly differentiated the
diseased animals with different
degrees of disabilities. We believe
that our method will be able to
predict the severity of disability
resulting from the spinal cord
lesions in patients with MS."

MALLINCKRODT INSTITUTE OF RADIOLOGY

Joshua Shimony,
MD, PhD

"A wonderful property of MRI
is that the signal can be conditioned
to produce different types of images,"
says Shimony, an assistant professor
of radiology and a neuroradiologist.
"With DTI, the signal can be programmed for sensitivity to microscopic movement of water molecules.
Diffusion motion is determined by
a number of factors. Take a bucket
of water and drop a dot of ink into
it, and the ink spreads evenly in all
directions. That's an example of
unrestricted diffusion."
"In the brain or other biologic
tissue, there are many restrictions
to water movement: proteins, cell
walls, blood vessels, and the like,"
he adds. "All of these will block
water from spreading uniformly. "

^
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"Much can be learned from the
study of MS with DTI, since myelin
is a major cause of restriction in
the brain." says Shimony. "Myelin
forms the insulator around nerve
fibers and restricts water flow in a
certain way. As myelin is destroyed,
the diffusion patterns change, and
we can see less restriction."
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Axial and coronal views of the restriction of water diffusion in the normal brain. The black-and-white figures show
where the restriction is highest, mostly in the white matter. In the color figures, the direction of restriction is
coded by using different colors.

Shimony keeps up with Song's
research and looks at different
aspects of the same problem in his
NMSS pilot grant to study brain tissue by using a variation of DTI.
"Hundreds of scientific papers
have been written about the results
from using the DTI model. But, in
the lab, we have found some limitations, and there have been some
variations proposed to describe the
biology better. My proposal to the
MS Society is to study a new model
(which we called the constantoffset version of DTI, or DTCO),
involving patients with mild and
severe MS as well as patients with
no disease (called controls), to
determine whether this model
is more useful for staging the
diagnosis. Constant offset was the
simpest way to change the model
and has been shown by others in
our lab to fit the data better," he says.
DTCO detects water molecules
that are highly restricted in their
motion, such as those near a cell
boundary. Early findings indicate

this technique may increase the
ability of DTI to detect differences
in types of tissue damage. Shimony,
with the assistance of Larry
Bretthorst, PhD, a staff scientist in
the Institute's Biomedical Magnetic
Resonance Laboratory, developed
the software to analyze data with
the new model, and 12 patients
have already been scanned by
Shimony's research assistant
Adrian Epstein. After 15 patients
(the study's goal) have been
scanned, Shimony will analyze
the data and compare it to the data
from control subjects that have
been scanned previously. Hopefully,
the constant-offset model will provide new noninvasive ways to view
different types and amounts of
tissue damage and tissue recovery;
all are important in predicting prognosis and the effect of different
therapies on the disease.
"The information gains should
help to target additional research
that will further the quest for a
cure," says Shimony.
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Sclerosis
Patients with MS can have one of four
forms of the disease. Each form of MS
can produce mild, moderate, or
severe symptoms.
Relapsing-Remitting—Most common (85%). Patients experience flare-ups (also called relapses, attacks, or exacerbations). Includes
episodes of acute worsening of neurological function, followed by partial or complete recovery (remission).
Primary-Progressive—Rare (approximately 10%). Patients
experience slow but continuous worsening of the disease from the
onset, with no distinct relapses or remissions. Includes variations in
rates of progression over time, occasional plateaus, and temporary
minor improvements.
Secondary-Progressive—Before the availability of "diseasemodifying" drugs, one half of patients with relapsing-remitting MS
developed the secondary-progressive form of the disease within 10
years of their initial diagnosis. Patients experience an initial period of
relapsing-remitting MS, followed by steadily worsening symptoms
(with or without occasional flare-ups), minor recoveries (remissions), or
plateaus. Long-term data are not yet available to demonstrate if development is significantly delayed by treatment.
Progressive-Relapsing—Rare (approximately 5%). Patients
experience steadily worsening symptoms from the onset but also have
clear, acute relapses (attacks or exacerbations), with or without recovery. The periods between relapses are characterized by continuing disease progression.
Additional information available on the National Multiple Sclerosis Society
Web site: www.nationalmssociety.org.

Tammie Benzinger,
MD, PhD
Benzinger, an instructor in
radiology and a neuroradiologist,
has an NMSS pilot grant to study
perhaps the most vulnerable
segment of the MS population:
children. Although MS is largely an
adult disease, 2.5 percent of MS
patients are children—and their
prognosis is usually more serious.
Children also are more prone
to other diseases such as acute
disseminated encephalomyelitis
(ADEM), which can be an
MS look-alike.
"ADEM can occur after a
viral or bacterial infection, or even
after an immunization. It is a selflimiting autoimmune response in
the brain. In children who have
ADEM, symptoms usually regress
within three months, even without
treatment," explains Benzinger.
"However, those symptoms can
mimic a chronic debilitating
disease like MS, which should be
treated early. A certain number of
children with ADEM do recover
but develop MS in adulthood. The
problem is how to determine injury
to the nerves versus the reversible
myelin injury. If patients have
nerve injury, even if the symptoms
go away, they seem to be at greater
risk for MS later."
"This study is a clinical application of Doctor Song's work with
the mouse model," she adds. "My
hypothesis is that the nature of
the white matter lesions can be
discriminated between myelin
injury and axon injury in human
patients by using DTI as the MR
biomarker for white matter injury."
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The histopathology of
ADEM and pediatric MS
are markedly similar: Both
have demyelination,
inflammation, and axon
injury, but in different
proportions. Even in fatal
cases, ADEM demyelination has limited axon loss
(nerve injury). However,
in patients with MS, axon
loss occurs early in the
disease—most prominently
within the first year—so
early treatment is crucial.
Benzinger believes that by
using DTI, physicians could
differentiate between
myelin and nerve injury,
giving a better indication as to
whether the patient should be
closely monitored or started on
aggressive therapy. Current guidelines for MS stress early treatment
for the best outcomes.
Her study involves ill children
during the acute phase of ADEM.
Up to 20 percent of patients initially diagnosed as having ADEM
are later reclassified as having MS.

Model of water diffusivity in myelinated axons

>i-axial = X|| =_1
X-radial = (_2 + _3)/2

(decreased with axonal injury)
(increased with myelin damage)
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"There are no large studies of
these children," Benzinger says.
"I'm collaborating with Doctor Soe
Mar, from the pediatric neurology
department at Saint Louis Children's Hospital,who runs a clinic
for pediatric demyelination. By
comparing the disease process of
children diagnosed with ADEM or
MS and of children who are experiencing a first demyelinating event,
we hope to determine whether DTI

"The problem is how to determine injury
to the nerves versus the reversible
myelin injury..."
Study patients initially will undergo
DTI scanning with a clinical visit
and will return in six months for
another scan and visit. Also participating in the study are patients
who were diagnosed up to 15 years
ago; after they undergo DTI with
a clinical visit, Benzinger will
compare their initial and final
diagnoses. She has identified 90
potential patients; 12 patients have
been enrolled in the study.

results can be useful to diagnose or
to confirm suspected diagnoses in
these children."
Early, accurate differential
diagnosis of these diseases could
be critical to children and to their
families by quickly identifying
children who could benefit from early
treatment of MS and sparing those
with ADEM whose symptoms will
regress without treatment. 013

Top: Schematic diagram of spinal cord axons (left) and ellipsoid
model of water diffusivity within axon bundle (right); both have
the MRI scanner x, y, and z axes superimposed.
Middle: Pediatric MS—Axial fluid attenuation inversion recovery
(FLAIR) image (left) shows multiple lesions. MRI exam (right) shows
less prominent initial lesions and at least one new lesion (arrow).
Bottom: Pediatric Multiphasic ADEM—Researchers predict that
the DTI technique will enable physicians to accurately diagnose
ADEM and to predict a long-term prognosis.
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RESEARCH STUDY
• WOULD YOU LIKE TO HELP RESEARCHERS LEARN MORE
ABOUT MEMORY CAPABILITY IN OLDER ADULTS?
• DO YOU HAVE A BROTHER OR SISTER WHO IS WITHIN FOUR
YEARS OF YOUR AGE?

• ARE YOU OR YOUR SIBLING BETWEEN THE
AGES OF 70 AND 75?
Vi olunteers are needed for a Washington University
School of Medicine/Mallinckrodt Institute of Radiology
brain imaging study. Both you and your sibling must
be able to participate in the study Note: if you have had
a metal device, such as a pacemaker, implanted due to surgery or
injury, you may not be eligible for the study.
Eligible volunteers will undergo the following:
• positron emission tomography (PET) scan
• magnetic resonance (MR) scan
• memory assessment
Volunteers will be compensated for their time and participation.

FOR MORE INFORMATION, CALL

314-362-1558.
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F
this section, the names of employees who are full-time
rulty or staff or who have an appointment in the
,'partment of Radiology are highlighted in boldface type.

IEW FACULTY
illiam Spees, PhD,
search instructor in radioligy, Division of Radiological
Sciences.

| JOINT
I APPOINTMENTS
Dione Farria, MD, MPH,
! assistant professor of radiology, was appointed adjunct
professor, Department of
Community Health, Saint
Louis University School of
Public Health.

GRANTS
Tammie Benzinger, MD,
PhD, instructor in radiology,
as principle investigator,
received a $44,000 pilot
grant from the National
Multiple Sclerosis Society
for her research on "Directional diffusivity as an MR
biomarker in childhood
demyelinating disease."
Coinvestigators for the oneyear grant are Soe Mar, MD,
Department of Neurology;
Sheng-Kwei Song, PhD,
associate professor of radiology; and Anne Cross, MD,
Department of Neurology.
Delphine Chen, MD,
instructor of radiology, as
principal investigator,
received a $772,355 grant
from the National Institutes
of Health/National Institute
of Biomedical Imaging and
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Bioengineering to study
"Apoptosis and inflammation
imaging." Mentors for the
five-year grant are Robert
Mach, PhD, professor of
radiology and of cell biology
and physiology; and Mark
Mintun, MD, professor of
radiology and of psychiatry.
She also received a $450,000
grant from the Damon
Runyon Cancer Research
Foundation to investigate
"Apoptosis imaging." Mentors
for the three-year Clinical
Investigator Award are Mach
and Michael Welch, PhD,
professor of radiology, of
chemistry, and of molecular
biology and pharmacology.
Nirvikar Dahiya, MD,
abdominal imaging clinical
fellow, as principal investigator, received a $10,000 Education and Research grant
from the American Institute
of Ultrasound in Medicine to
study "Tendinopathy of the
rotator cuff: correlation of
ultrasonographic findings
with histopathologic
changes using a cadaver
shoulder model."
Igor Efimov, PhD, associate
professor of biomedical
engineering and of radiology,
received a four-year subcontract in the amount of
$805,819 from the National
Institutes of Health to
investigate "Defibrillation
mechanisms in infracted
hearts." As principal investigator, he received a twoyear, $143,000 grant-in-aid
from the American Heart
Association for research on
"Structure of the human AV
junction."

Dionne Farria, MD, MPH,
assistant professor of radiology, received a $10,350 STEP
grant from the St. Louis Affiliate of Susan G. Komen for
the Cure to study "Reducing
delays in breast cancer diagnosis in the St. Louis Public
Safety Net system." Coinvestigators are Katherine Mathews, MD, Department of
Obstetrics and Gynecology;
and Susan Kraenzle, RN,
manager of the Breast
Health Center at the Alvin
J. Siteman Cancer Center.
Jeffrey Lin, MD, PhD, a
third-year diagnostic radiology resident, received a
$30,000 seed grant from the
Radiological Society of
North America to study
"Noninvasive characterization
of NFkB activation in nonalcoholic fatty liver disease."
David Piwnica-Worms,
MD, PhD, professor of
radiology and of molecular
biology and pharmacology,
is faculty mentor for the
one-year grant.
Joel Perlmutter, MD,
professor of neurology, of
radiology, and of physical
therapy, received a National
Institutes of Health subcontract of $195,000 to investigate "Pathophysiology of
dystonia and parkinsonism."
The subcontract is through a
five-year grant awarded to
Jonathan Mink, MD, University of Rochester. As principal investigator, Perlmutter
received a one-year, $50,000
grant from the Huntington
Disease Society of America
for his project "Huntington's
Disease Center of Excellence."

Joshua Shimony, MD,
PhD, assistant professor
of radiology, received a
$125,000 grant from the
National Institutes of
Health/National Institute
of Child Health and Human
Development for research on
"A Bayesian approach to MR
tractography in the developing brain." Coinvestigators
for the five-year grant are
Jeffrey Neil, MD, PhD,
professor of neurology, of
pediatrics, of neurological
surgery, and of radiology;
Terrie Inder, MD, Department
of Pediatrics; Robert
McKinstry, MD, PhD, associate professor of radiology;
and Larry Bretthorst, PhD,
staff scientist.
Marilyn Siegel, MD,
professor of radiology
and of pediatrics, received
a $30,000 seed grant from
the Radiological Society of
North America for research
on "Hyperpolarized helium-3
MRI assessment of bronchiolitis obliterans in pediatric
lung transplant recipients."
Collaborators for the oneyear grant are Dmitriy
Yablonskiy, PhD, professor
of radiology and of physics;
Mark Conradi, PhD, professor of physics, of radiology, and of chemistry;
David Gierada, MD, associate professor of radiology;
Charles Hildebolt, DDS,
PhD, associate professor of
radiology and adjunct
associate professor of
anthropology; and Stuart
Sweet, MD, PhD, Department of Pediatrics.
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GRANTS
Continued from page 27
Karen Wooley, PhD,
professor of chemistry and
of radiology, received a twoyear grant of $200,000 (total
award) from Children's Discovery Institute, a research
partnership between St.
Louis Children's Hospital
and Washington University
in St. Louis, for research on
"Hyperbranched fluoropolymers (HBFP(III)), designed
as complex nanostructures
for imaging and therapeutic
delivery in the diagnosis and
treatment of pediatric brain
cancers."

APPOINTMENTS/
ELECTIONS
William McAlister, MD,
professor of radiology and of
pediatrics, was appointed to
the Board of Directors of the
Research and Education
Foundation of the Society
for Pediatric Radiology.
Joel Perlmutter, MD,
professor of neurology, of
radiology, and of physical
therapy, was appointed
cochair of the Mentoring
Committee for the Parkinson
Study group.
Yoram Rudy, PhD, professor
of engineering, cell biology
and physiology, and of medicine, and research professor
of radiology, was elected to
a one-year term on the Board
of Directors for the International Society for Computerized Electrocardiology. He
was elected to a two-year
term as president of the
Cardiac Electrophysiology
Society.
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Karen Wooley, PhD,
professor of chemistry and
of radiology, was appointed
to the editorial advisory
boards of Bioconjugate
Chemistry and the Journal
of the American Chemical
Society. She was appointed
to the External Advisory
Committee of the National
Science Foundation-Partnership for Research and
Education in Materials
(NSF-PREM) Program with
the University of California,
Santa Barbara. She also was
appointed chair of the 2007
Polymers (East) Gordon
Research Conference.
Pamela Woodard, MD,
associate professor of
radiology, was appointed
to the Editorial Board of
the Journal of Magnetic
Resonance Imaging.

HONORS/
AWARDS
Yasha Kadkhodayan, MD,
first-year diagnostic radiology
resident, received a 2007
Society of Interventional
Radiology Resident-inTraining Scholarship, which
funded his attendance at the
Society's 32"" Annual Scientific
Meeting in Seattle, Washington, March 1-6.
Jonathan McConathy, MD,
PhD, a second-year diagnostic
radiology resident, was one
of 80 residents nationwide
chosen to participate in the
Introduction to Research
Program at the American
Roentgen Ray Society's 107"'
Annual Meeting in Orlando,
Florida, May 6-11.

Constantine Raptis, MD,
a second-year diagnostic
radiology resident, was one
of 35 residents in the United
States selected to attend the
Siemens-Association of
University Radiologists
(AUR) Radiology Resident
Academic Development
(SARRAD) Program at the
AUR's 55°' Annual Meeting in
Denver, Colorado, April 24-28.

Dionne Farria, MD, MPH,
assistant professor of radiology, spoke on "Imaging
approach to the symptomatic
breast" and "Imaging evaluation of breast implants" at
Women's Health and Imaging
in a Digital Environment,
San Antonio, Texas, January
22. She presented "Screening
strategies and minority outreach" at the Cancer Centers
Administrators Forum
Annual Meeting, St. Louis,
Missouri, March 26.

LECTURES

Perry Grigsby, MD, professor of radiation oncology
and of radiology, presented
"Gynecologic radiation
oncology: cervical cancer";
"Gynecologic radiation
oncology: endometrial
cancer"; and "Gynecologic
radiation oncology: 'How I
do it' technical aspects of
gynecologic brachytherapy"
at the Midwinter Radiation
Oncology Conference, Los
Angeles, California, January
21. As visiting professor, he
spoke on "Radiotherapy for
endometrial cancer" and
"FDG-PET in cervical cancer"
at Stanford University, Palo
Alto, California, March 2 and
3. Grigsby presented "The
contribution of new imaging
techniques in staging system";
"Multi-modality treatments:
an update"; "Role of imaging
Special issues after radiati m
therapy"; and "Tomotherai >y
for gynecologic cancers" ai
the 5"1 International Confei
ence on Cervical Cancer,
Venice Lido, Italy, April 13
18. He presented "IGRT h< vv
to: pelvis" at the American
Society for Therapeutic
Radiology and Oncology

Igor Efimov, PhD, associate professor of biomedical
engineering and of radiology,
presented "New approaches
to device therapy of cardiac
arrhythmias: insights from
optical imaging" at the Bioengineering Leaders Seminar
Series, sponsored by the
Department of Biomedical
Engineering, Duke University,
Durham, North Carolina,
January 8. He presented
"Optical imaging of arrhythmias" at the University of
Missouri—St. Louis, January
12. He spoke on "New
advances towards painless
defibrillation" and "Sinoatrial
and atrioventricular nodal
structure and function" at
the Saudi Heart Rhythm
Society Satellite Symposium,
the Saudi Heart Association
XVm Annual Meeting, Jeddah,
Kingdom of Saudi Arabia,
February 7. He spoke on
"New approaches to device
therapy of cardiac arrhythmias: insights from optical
imaging" at the Lillehei Heart
Institute Grand Rounds,
University of Minnesota,
Minneapolis, March 6.
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] lage Guided Radiotherapy
i JRT) Symposium, St.
tersburg, Florida, April 22.
■ spoke on "Innovations in
I achytherapy" at the 28th
Annual Meeting of the American Brachytherapy Society,
( liicago, Illinois, April 28.
jay Heiken, MD, professor
uf radiology, as visiting
professor, spoke on "CT of
! lie abdominal aorta: diagnosing aneurysm rupture"
and "Distinguishing benign
from malignant liver lesions
with CT and MRI" at the
Medical College of Wisconsin,
Milwaukee, January 22. He
presented "CT colonography
for colorectal cancer screening: current status"; "Benign
liver masses: detection and
characterization with CT and
MRI;" and "Hepatocellular
carcinoma: imaging evaluation
with MRI" at Cancer Imaging
2007, the Joint Meeting of
the International Cancer

Imaging Society and the
Hong Kong College of
Radiologists, Hong Kong
SAR, People's Republic of
China, February 10 and 11.
Jason Lewis, PhD, assistant
professor of radiology,
spoke on "PET imaging of
cancer with copper-64thiosemicarbazones" at the
Joint Program in Nuclear
Medicine, Harvard Medical
School, Boston, Massachusetts, January 18.
Robert McKinstry, MD,
PhD, associate professor
of radiology, spoke on
"The triple threat: living the
dream" at the HarvardMassachusetts Institute of
Technology Division of
Health Sciences and Technology Alumni Roundtable,
Boston, Massachusetts, May 1.

Joel Perlmutter, MD,
professor of neurology, of
radiology, and of physical
therapy, presented "Neuroimaging of Parkinson
disease progression" at the
International Society for
CNS Clinical Trial
Methodology/Michael J. Fox
Foundation Meeting on
Neuroprotective Trials in
Parkinson Disease, Washington, DC, February 11. He
presented "Mentoring new
investigators in clinical
research" and "Neuroimaging
of Parkinson disease biomarkers" to The Parkinson
Study Group, American
Academy of Neurology,
Boston, Massachusetts,
April 29 and 30.
Yoram Rudy, PhD, professor
of engineering, cell biology
and physiology, and of medicine, and research professor
of radiology, presented
"From genetics to cellular
function using computational
biology" to the Center for
Neurodynamics, Department
of Physics and Astronomy,
University of Missouri—
St. Louis, February 23. He
spoke on "Computational

Biello Lecture
David Townsend, PhD, director of
the Cancer Imaging and Tracer
Development Research Program,
University of Tennessee Medical
Center, was guest lecturer for the
21sl Annual Daniel R. Biello Memorial Lecture on March 14. He spoke
on "The evolution of PET/CT: a path
of no return."
Townsend (left) is shown with Barry Siegel, MD, chief of the Division
of Nuclear Medicine and coordinator of the Biello Lecture.
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biology and noninvasive
imaging of cardiac arrhythmia"
at the Frontiers in Human
Pathobiology Seminar Series,
Washington University in
St. Louis School of Medicine,
March 7. He spoke on
"Cardiac Repolarization
and Arrhythmia: mechanistic
insights from computational
biology" at the Cardiovascular
Research Center, Department
of Medicine, University of
Iowa, Iowa City, March 9. He
presented "Imaging Arrhythmias in humans: electrocardiographic imaging (ECGI)"
at the Gordon Research
Conference on Cardiac
Arrhythmia Mechanisms,
Ventura Beach, California,
March 18.
Barry Siegel, MD, professor
of radiology and of medicine,
spoke on "National Oncologic
PET Registry (NOPR),"
"PET/CT of gynecologic
cancers," and "PET/CT of
breast cancer" at the First
Annual PET/CT Update,
sponsored by the American
College of Radiology, Boca
Raton, Florida, January
28-31. He presented "PET/CT
in oncology diagnosis'; "Evolution of PET reimbursement
and the National Oncologic
PET Registry': and "PET in
oncology: beyond FDG" at
the 22n" Annual Cross-sectional Imaging Conference,
sponsored by the University
of Pennsylvania School of
Medicine, St. John, U.S. Virgin
Islands, February 26-March 2.
He spoke on "National
Oncologic PET Registry,"
"Update: PET/CT in lung
cancer," and "Update:
PET/CT in gynecologic
malignancies" at Updates
on PET/CT Imaging for
Referring Physicians,
sponsored by Mount Sinai
School of Medicine, New
York, New York, April 20.
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LECTURES
Continued from page 29
Marilyn Siegel, MD,
professor of radiology and
of pediatrics, spoke on
"Congenital bowel diseases
in children" and "US/CT of
acute right lower quadrant
pain" at the 20lh Japanese
College of Radiology
Mid-Winter Seminar,
Fukuoka, Japan, January
18-21. She presented "CT of
the pediatric chest in routine
practice" and "Vascular
malformations of the pediatric
chest" at the 39"' International
Course on Diagnostic Imaging,
Davos, Switzerland, March
24-30. Siegel spoke on
"Sonography of acute bowel
disease," "Sonography of
neonatal hydronephrosis,"
and "Spinal ultrasonography"
at the 16th Annual Diagnostic
Ultrasound Symposium,
Toledo, Ohio, March 10. She
presented "Pediatric multi-

slice CT angiography: How I
do it" at the Society of Pediatric Radiology Annual Meeting, Miami, Florida, April 20.
Yuan-Chuan Tai, PhD,
assistant professor of radiology, presented "Positron
emission tomography—
principles and applications"
to the Department of Nuclear,
Plasma, and Radiological
Engineering, University of
Illinois at Urbana-Champaign,
February 6.
Karen Wooley, PhD,
professor of chemistry and
of radiology, presented
"Complex, amphiphilic
polymer nanostructures,
originating from combinations
of living polymerizations,
supramolecular assembly
and regioselective crosslinking" to the Department of
Chemistry, Columbia University, New York, New York,

February 1. She spoke on
"The promise of nanotechnology in medicine" at the
Frontiers in Human Pathobiology Seminar Series,
Washington University in
St. Louis School of Medicine,
February 14. Wooley spoke
on "Crafting organic nanostructures with well-defined
size, shape, structure and
properties" at the ChemistryBiology Interface Seminar,
University of Illinois at
Urbana-Champaign, March
12. She presented "Complex
constructs having nanoscale
features by combining
incompatible polymer components" and "Nanoparticles
and nanocages originating
from well-defined brush
block copolymers" at the
233rd American Chemical
Society National Meeting &
Exposition, Chicago, Illinois,
March 25-29.

Pamela Woodard, MD,
associate professor of radiology, spoke on "Basic cardiac
MRU and "Delayed contrastenhanced cardiac MRI" at
the Armed Forces Institute
of Pathology, Bethesda,
Maryland, January 22, March
19, and April 23.

SYMPOSIA
In this section ofFYI, only
those faculty and staff who
have Department of Radiology appointments are listed,
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SOCIETY OF INTERVENTIONS. RADIOLOGISTS
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32"d Annual Scientific Meeting
Seattle, Washington
March 1-6, 2007
Daniel Brown, MD, workshop coordinator, Gastrointestinal IR: Techniques and
Management.
Daniel Picus, MD, panelist,
Case Based Review: NonVascular Interventions.
Suresh Vedantham, MD,
workshop coordinator,
Thrombolytic Therapy of
Venous Thrombolysis.

Senturia Lecture

James Duncan, MD, PhD;
Craig Glaiberman, MD;
Benjamin Jacobs, "Expert
Performance Evaluation
Using Real Time Simulated
Environments: data
extracted from the
EXPERTISE protocol."

On May 2, Lane Donnelly, MD, radiologist
-in-chief at Cincinnati Children's Hospital,
presented "How to perform and interpret
MR cine sleep studies for obstructive
sleep apnea in children" at the 13"' Annual
Hyman R. Senturia Lecture.
Robert McKinstry, MD, PhD, chief of pediatric radiology, presented Donnelly (right) with a commemorative plaque.
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James Duncan, MD, PhD:
Craig Glaiberman, MD,
"Analysis of simulated angi
graphic procedures: extraci
ing efficiency data from
audio and video recordings
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Craig Glaiberman, MD;
James Duncan, MD, PhD,
"Measuring proficiency
during renal artery stent
placement using a high
fidelity medical simulator."
Ashesh Parikh, MD; James
Duncan, MD, PhD; Craig
Glaiberman, MD, "Recording datasets for performance
assessment during medical
procedures."

i

WORKSHOPS
Dennis Balfe, MD, "ABR
Update—2007."
Jay Heiken, MD, "Imaging
the pancreas: neoplastic and
inflammatory disease."

Karun Sharma, MD, PhD;
Jennifer Gould, MD;
Daniel Brown, MD,
"Survivial following hepatic
arterial chemoembolization
(HACE) for liver dominant
melanoma metastases."

Sharlene Teefey, MD,
"Ultrasound evaluation of
TIPS."

Pamela Woodard, MD,
"Cardiac CT: non-coronary
applications."

SOCIETY FOR PEDIATRIC
RADIOLOGY

SOCIETY OF BREAST
IMAGING
<§"' Post Graduate Course
Hollywood, Florida
April 14-17, 2007

)

PRESENTATION
Jay Heiken, MD, "Hepatic
masses: distinguishing
benign from malignant
lesions."

REFRESHER COURSE
Dionne Faria, MD, MPH,
"Work up of masses."

\
||

PANEL DISCUSSION
Barbara Monsees, MD,
"Workflow issues."

:

SOCIETY OF GASTROINTESTINAL RADIOLOGISTS
AND SOCIETY OF
URORADIOLOGY
Abdominal Radiology
Course 2007
Bonita Springs, Florida
April 15-20, 2007
IN-CAMERA SESSION
Jay Heiken, MD, "How can
we ensure high quality CT
colonography?"
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Christine Menias, MD,
"CT evaluation of lower
abdominal pain."

50"' Annual Meeting and
Postgraduate Course
Miami, Florida
April 17-21, 2007

CONFERENCE OF
NUCLEAR CARDIOLOGY
8"' International
Prague, Czech Republic
April 29-May 2, 2007
SCIENTIFIC PRESENTATIONS
Robert Gropler, MD, "The
future of nuclear cardiology"; "Role of nuclear techniques and hybrids."
POSTER PRESENTATION
Pilar Herrero, MS; Donna
Lesniak, RN; Carmen
Dence, MS; Zulfia
Kisrieva-Ware, MD, PhD;
Robert Gropler, MD,
"Impact of hyperinsulinemiceuglycemicclamp (HIEG)
during cardiac work on
myocardial glucose metabolism, oxidation and glycogen
formation in type 1 diabetic
patients."

INTERNATIONAL SYMPOSIUM ON RADIOPHARMACEUTICAL SCIENCES

17th Annual Meeting
Aachen, Germany
April 30-May 4, 2007

KEYNOTE ADDRESS
Michael Welch, PhD,
"Thirty years of ISRC:
changes and consistencies
with evolving methods and
targets."
SCIENTIFIC PRESENTATIONS
Laura Meyer; Martin
Eiblmaier; Carolyn
Anderson, PhD, "Potential
role of tumor suppressor
protein p53 in the trafficking
of copper to the nuclei of
tumor cells."
Amy Vavere, PhD; Jason
Lewis, PhD, "w Cu-labelling
and small animal PET imaging
of a Ph-dependent insertion
peptide-^Cu-DOTA-PHLIP."

POSTER PRESENTATIONS
William McAlister, MD,
"Deactivating germline mutations in LEMD3 cause
osteopoikilosis
and Buschke-Ollendorff syndrome but not melorheostosis."
William McAlister, MD,
"Hypophosphatasia: misleading in utero presentation for
childhood and odonto
forms."—Award of Honorable Mention
Prakash Masand, MD;
Rebecca Hulett Bowling,
MD, "Multislice CT in
the evaluation of unusual
pediatric masses."

RADIONUCLIDE RESOURCE
FOR CANCER APPLICATIONS
AN

NC I - SPONSORED

AT WASHINGTON

PROGRAM

UNIVERSITY

Jason Lewis, PhD; Lucie Tang; and Michael Welch, PhD, of
Mallinckrodt Institute's Division of Radiological Sciences, were
the organizers of "Production and Application of 'Non-Standard'
PET Nuclides"—the April 29th satellite workshop that coincided with the 17th International Symposium on Radiopharmaceutical Sciences (ISRS) in Aachen, Germany. Presenters at the
workshop, which was supported by a National Cancer Institute/National Institutes of Health grant, discussed the production, use, and dissemination of the "non-standard" PET nuclides.
More than 100 scientists and engineers from 20 countries
attended the successful event, which will be offered again in
2009 at the 18th International ISRS.

31

SYMPOSIA
Continued from page 31
Raffaella Rossin, PhD;
Michael Welch, PhD,
"Small animal PET imaging
of tumor vasculature using a
7ll
Br-labeled human recombinant anti-ED-B fibronectin
antibody fragment."
Aviv Hagooly, PhD;
Raffaella Rossin, PhD;
Michael Welch, PhD,
"Novel nanocarriers for
imaging and drug delivery:
in vivo evaluation of
"Cu-labeled PEG graft
copolymers."

POSTER PRESENTATIONS
Dong Zhou, PhD; Wenhua
Chu; Justin Rothfuss;
Lynne Jones; Chenbo
Zeng; Jinbin Xu; Delphine
Chen, MD; Michael Welch,
PhD; Robert Mach, PhD,
"Radiolabeling and labeling
mechanism of ['»F]WC-II-89
for imaging caspase-3 activation in apoptosis."
Carmen Dence, MS;
Jason Paisley; Sally
Schwarz, RPh, MS;
Stephany Shockley; Mark
Minton, MD; Robert Mach,
PhD; Michael Welch, PhD,
"Methodology for the routine
synthesis of ["C]PK-11195 at
WUSM."
Christopher Bognar;
Gregory Gaehle; Jeffrey
Willits; Carmen Dence,
MS; Michael Welch, PhD,
"Utilizing a versatile inexpensive catalyst 5 robot to
synthesize [lsF]fluorodihydrotestosterone (,SF-FDHT)."
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Gregory Gaehle; Jeffrey
Willits; Stephen Moerlein,
PhD; Robert Mach, PhD;
Michael Welch, PhD,
"Automated production of
[18F]fluorodopa injection,
USP."
Thaddeus Wadas; Ashley
Fiamengo; Christopher
Sherman; Carolyn Anderson, PhD, "In vivo evaluation of MCu-labelled
cross-bridged tetraazamacrocyclic complexes with
amide and/or carboxylate
functional groups."
David Reichert, PhD;
Jeosong Yoo, "Cyclen-based
copper complexes as potential estrogen receptor ligands: synthesis, binding
affinity, and computer
modeling."
Wilson Edwards, PhD;
Samuel Achilefu, PhD;
Buck Rogers, PhD, "Evaluation of gene transfer using
an adenoviral vector encoding
somatostatin receptor subtype 2 fused to enhanced
green fluorescent protein."
Carmen Dence, MS;
Michael Welch, PhD,
"Synthesis and in vivo
characterization of high
affinity androgens to evaluate
the role of SHBG in radiosteroid delivery."
Hsiaoju Lee; Michael
Welch, PhD; Robert Mach,
PhD, "Developing 18Flabeled PPAR gamma antagonists for PET imaging."
Zhude Tu, PhD; Robert
Mach, PhD, "Design and
synthesis of potent and
selective fluorinated
dopamine D receptor
ligands."

Stephany Shockley;
Stephen Moerlein, PhD;
Michael Welch, PhD,
"Evaluation of the peripheral
benzodiazepine receptor
as a marker of proliferation."
Zhude Tu, PhD; Jinbin Xu;
Lynne Jones; Delphine
Chen, MD; Mark Mintun,
MD; Joel Perlmutter, MD;
Robert Mach, PhD,
"Radiosynthesis and in vivo
and vitro evaluation of an
18
F-labeled radiotracer for
imaging dopamine D3 receptors in the CNS."
Martin Eiblmaier; Richard
Laforest, PhD; Buck
Rogers, PhD; Carolyn
Anderson, PhD, "Internalization, efflux, and dosimetry
of two "Cu-labeled somatostatin analogs in a human
SSTr2-transfected cell line."
Michael Welch, PhD;
Jason Lewis, PhD, "Synthesis and characterization of
"Y-, ^Ga- and lnIn-CHXA
ReCCMSH(ARGll)
melanoma targeting peptides."
Raffaella Rossin; Zhaohui
Zhou; James Kozlowski;
Michael Welch, PhD;
Daniel Schuster, MD, "PET
imaging of lung endothelium
with "Cu-labeled targeted
nanoparticles."
Amy Vavere, PhD; Jason
Lewis, PhD, "Diminished
CU-ATSM hypoxia selectivity
and its relation to fatty acid
synthase expression in
prostate tumors."

Carmen Dence, MS;
Richard Laforest, PhD;
Terry Sharp; Robert
Mach, PhD; Michael
Welch, PhD, ""C-methylated
LY2181308, an antisense
oligonucleotide to surviving:
Part II - human dosimetry
calculation."

AMERICAN ROENTGEN
RAY SOCIETY
107" Annual Meeting
Orlando, Florida
May 6-11, 2007
Sanjeev Bhalla, MD,
section chair, Cardiovascular
Imaging.

PRESENTATIONS
Sanjeev BhaUa, MD,
"Cardiovascular imaging:
acquired cardiac"; "Pulmonary embolic disease";
"Nonthromboembolic
pulmonary embolism."
Cylen Javidan-Nejad, MD,
"Cardiovascular imaging:
congenital."
Christine Menias, MD,
"Imaging nontraumatic
abdominal pain including the
pregnant patient: CT, MR or
Ultrasound?"
Marilyn Siegel, MD, "Pedi
atric congenital heart disease:
CTA/MRA and cardiac
lesions"; "Neonatal neurosonography."
Pamela Woodard, MD,
"First trimester ultrasound

EXHIBITS
Prakash Masand, MD,
"Multislice CT imaging of
unusual pediatric renal
masses."
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summer, is a sophisticated bioimaging facility for basic and translational inpatient
and outpatient clinical research. Investigators in the 9,000-square-foot facility, on
the 10th floor of Barnes-Jewish Hospital's West Pavilion, will conduct research in
computed tomography (CT), positron emission tomography (PET), magnetic
resonance (MR), combined PET/CT, and ultrasound. Shown here is the April 2007
installation of a massive MR scanner.
Photograph by Mickey Wynn, MIR Photography Lab.
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